Xi'an International Medical Investment Company Limited

Company Profile

As the first listed company in Shaanxi Province and northwestern china, in recent years, the company has focused its development strategy on the medical service and modern medical technology, constantly improving its corporate governance, and formed development strategy with scientific and technological innovation and steady operation, at the same time, the capital strength is keep growing, and the company now become one of the largest listed medical industry groups. The Company uses superior resources to accelerate development of its main business and its medical service business is growing rapidly. Two comprehensive hospital campuses of the Company, Xi’an International Medical Center Hospital (JCI accredited hospital) , Gaoxin Hospital (the first private Grade-3 Class-A hospital in China) are fully utilized to effectively expand the operation of the Company and improve its medical business strength. The industrial impact and market competitiveness of the Company have been significantly improved, which marks the formation of its cross-regional medical service network around Xi’an proper. This is a milestone of the Company in setting up a life cycle grand health service platform with medical services at the core. In the future, the company will be devoted to the construction of medical service network covering Western China with capital as the link; By tracking advanced medical science and technologies, the Company will continue to invest more in the fields of medical services and high-tech life science, build a large health industry chain with synergetic development, and develop into a health management group with great influence in China. The Company focuses the grand health industry and cooperates with domestic and overseas strategic partners deeply to promote development of the health industry of China. Its partners include famous medical service institutions, medical instrument enterprises in the United States, Britain, Japan, Germany, South Korea. In 2021, Xi’an International Medical Center Hospital, and Xi'an Gaoxin Hospital officially join Mayo Clinic Care Network. Through this network Mayo Clinic will share knowledge, expertise and resources with International Medical, and work together to advance medical science and enhance the delivery of care. The assisted reproductive medical project of the Company was approved by the health administration at the beginning of 2019. Now the Company has officially started the intrauterine insemination (IUI) service. The Company will carry out in vitro fertilization (IVF) business after obtaining approval from the health administration. In addition, the Company maintains in-depth exchanges and cooperation with famous domestic and international medical institutions, to introduce excellent talents, advanced technologies and service ideas, as well as builds leading disciplines. The Company aims to establish multinational and cross-regional medical cooperative mechanisms with high-quality medical institutions, so as to provide satisfactory medical services for patients and meet their differential medical demands.